艾伯特·爱因斯坦医学院每年从NIAID获得1 400万美元的年度赠款,以领导一项全国性倡议,即PROVIDENT,为新出现的病毒创建“插管和手术”疫苗和抗体疗法。 Albert Einstein College of Medicine secures a $14M annual grant from NIAID to lead a national initiative, PROVIDENT, for creating "plug-and-play" vaccines and antibody therapies for emerging viruses.
阿尔伯特·爱因斯坦医学院获得了NIAID的五年,每年1400万美元的资助,以领导旨在为新出现的病毒制造"插入和使用"疫苗和抗体疗法的国家计划. Albert Einstein College of Medicine has secured a five-year, $14 million annual grant from the NIAID to lead a national initiative aimed at creating "plug-and-play" vaccines and antibody therapies for emerging viruses. 该项目名为PROVIDENT,涉及来自学术界、政府和工业界的13个小组,侧重于奈罗病毒、汉塔病毒和parmyxo病毒。 This project, named PROVIDENT, involves 13 teams from academia, government, and industry, focusing on nairoviruses, hantaviruses, and paramyxoviruses. 这项工作是REVAMPP网络的一部分,该网络每年承诺约1亿美元用于大流行病防备研究。 The effort is part of the ReVAMPP Network, which commits around $100 million yearly for pandemic preparedness research.